Monster Beverage stock price target raised to $74 by Morgan Stanley

Morgan Stanley has raised its price target for Monster Beverage (MNST) to $74.00 from $70.00, maintaining an Overweight rating, following the energy drink giant's robust second-quarter 2025 performance. Monster significantly surpassed analyst expectations, reporting EPS 7.2% above consensus and revenue exceeding forecasts, alongside strong July sales growth of 23% excluding foreign exchange and alcohol. This strong operational momentum, coupled with potential U.S. price increases, led Morgan Stanley to increase its fiscal year 2025 and 2026 earnings per share estimates by 2.5% each, underpinning the revised valuation.

Analysis

Morgan Stanley has upgraded its price target on Monster Beverage (MNST) to $74.00 from $70.00, maintaining an Overweight rating, following a robust second-quarter 2025 performance that exceeded market expectations. The company reported earnings per share of $0.52, a 7.2% beat over the $0.48 consensus, and revenue of $2.11 billion, surpassing the $2.08 billion forecast. This outperformance was supported by a 115 basis point beat on gross margins, with overall gross profit margins standing at a strong 54.64%. Critically, operational momentum appears to be accelerating into the third quarter, evidenced by robust July sales growth of 23% (excluding foreign exchange and alcohol), which significantly outpaces Morgan Stanley's low-double-digit forecast. The 11.1% global organic sales growth in Q2 was primarily driven by international markets outperforming consensus. In response, Morgan Stanley has raised its fiscal year 2025 and 2026 EPS estimates by 2.5% each, basing its new price target on a multiple of approximately 26x FY2026 EV/EBITDA. While the company's fundamentals and forward guidance are strong, including potential Q4 price increases to offset tariff pressures, it is noted that the stock has already seen a 30.5% price return over the past six months and some analyses suggest it is trading slightly above its fair value.

Key Decisions for Investors

• The strong Q2 earnings beat, upward EPS revisions, and accelerating sales momentum into Q3 provide a fundamental basis to support or initiate an overweight position.
• Investors should be mindful of the stock's significant 30.5% run-up over the past six months and valuation metrics that suggest it may be trading above fair value, warranting a disciplined approach to entry points.
• Monitor the execution and consumer reception of potential Q4 U.S. price increases, as their success in offsetting tariff pressures is crucial for sustaining margin strength and validating the higher price target.
• Continued outperformance in international sales is a key catalyst for growth, and these figures should be closely tracked in subsequent earnings reports.